BOLT

Bolt Biotherapeutics, Inc. Common Stock

5.83

USD

BOLT Earnings Reports

Positive Surprise Ratio

BOLT beat 15 of 20 last estimates.

75%

Next Report

Date of Next Report

Mar 23, 2026

Estimate for Q4 25 (Revenue/ EPS)

$680.00K

-$6.22

Implied change from Q3 25 (Revenue/ EPS)

-68.65%

+67.20%

Implied change from Q4 24 (Revenue/ EPS)

-18.16%

Bolt Biotherapeutics, Inc. Common Stock earnings per share and revenue

On Nov 12, 2025, BOLT reported earnings of -3.72 USD per share (EPS) for Q3 25, beating the estimate of -5.90 USD, resulting in a 36.99% surprise. Revenue reached 2.17 million, compared to an expected 739.50 thousand, with a 193.31% difference. The market reacted with a +0.21% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 7 analysts forecast an EPS of -6.22 USD, with revenue projected to reach 680.00 thousand USD, implying an increase of 67.20% EPS, and decrease of -68.65% in Revenue from the last quarter.

FAQ

What were Bolt Biotherapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Bolt Biotherapeutics, Inc. Common Stock reported EPS of -$3.72, beating estimates by 36.99%, and revenue of $2.17M, 193.31% above expectations.

How did the market react to Bolt Biotherapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 0.21%, changed from $4.69 before the earnings release to $4.70 the day after.

When is Bolt Biotherapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 23, 2026.

What are the forecasts for Bolt Biotherapeutics, Inc. Common Stock's next earnings report?

Based on 7 analysts, Bolt Biotherapeutics, Inc. Common Stock is expected to report EPS of -$6.22 and revenue of $680.00K for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.